Extracellular Matrix and Vesicles as Immunomodulatory Therapeutics
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Gene and Cell Therapy".
Deadline for manuscript submissions: 31 March 2025 | Viewed by 87
Special Issue Editors
Interests: stem cells; secretome; extracellular vesicles; targeted drug delivery; gene and cell therapy; lung repair and regeneration
2. Viscus Biologics LLC., 2603 Miles Road, Cleveland, OH 44128, USA
Interests: medical devices; clinical translation; extracellular matrix; extracellular vesicles
Special Issues, Collections and Topics in MDPI journals
Interests: stem cells; tissue engineering; extracellular vesicles; biomaterials; immunology; ageing; extracellular matrix
Special Issues, Collections and Topics in MDPI journals
Interests: regenerative medicine; nanomedicine; mesenchymal stromal cells; targeted cell therapy; regeneration; cancer therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In this Special Issue of Pharmaceutics, titled “Extracellular Matrix and Vesicles as Immunomodulatory Therapeutics”, we delve into the implications of utilizing extracellular matrix (ECM)-based biomaterials and extracellular vesicles (EVs) as immune response-modulating agents. ECM and EVs play essential roles in the response and coordination of the immune system in health and disease, which qualifies them as powerful tools (both on their own or combined) for immunomodulatory agents. The importance of this field is further underscored by their potential to develop targeted immunotherapies and chronic inflammation treatments with enhanced efficacy and reduced side effects. Hence, the purpose of this Special Issue is to showcase the latest research on the pharmaceutical applications of ECM and extracellular vesicle-based therapeutics alone or combined, including their design, optimization, and therapeutic immunomodulatory efficacy. This collection aims to provide a comprehensive overview of how these innovative approaches can be harnessed to advance drug delivery and immunomodulation to clinical translation.
Dr. Amiq Gazdhar
Dr. Héctor Capella-Monsonís
Dr. William D’Angelo
Dr. Ana Isabel Flores
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- extracellular matrix
- extracellular vesicles
- inflammation
- immunomodulation
- regenerative medicine
- drug delivery
- clinical translation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
